Is BeiGene (BGNE) a Smart Long-Term Investment?

Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Asia Pacific UCITS Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. Longleaf Partners Asia Pacific UCITS Fund returned -7.48% in the first quarter, trailing the MSCI AC Asia Pacific Index. There is an immense opportunity to be in the right companies as they close that massive discount to a more reasonable discount versus global peers. Try to take some time looking at the fund’s top 5 holdings to be informed about their best picks for 2022.

In its Q1 2022 investor letter, Longleaf Partners Asia Pacific UCITS Fund mentioned BeiGene, Ltd. (NASDAQ:BGNE) and explained its insights for the company. Founded in 2010, BeiGene, Ltd. (NASDAQ:BGNE) is a Beijing, China-based biotechnology company with a $18.3 billion market capitalization. BeiGene, Ltd. (NASDAQ:BGNE) delivered a -34.66% return since the beginning of the year, while its 12-month returns are down by -46.54%. The stock closed at $177.02 per share on July 08, 2022.

Here is what Longleaf Partners Asia Pacific UCITS Fund has to say about BeiGene, Ltd. (NASDAQ:BGNE) in its Q1 2022 investor letter:

“One company that we do not hold, but that serves as a good example of corrective action, is BeiGene (NASDAQ:BGNE). The company recently switched auditors to Ernst & Young USA from Ernst & Young China for its US Securities and Exchange Commission (SEC) audit reports to avoid a de-listing in the US.”

louis-reed-pwcKF7L4-no-unsplash

Our calculations show that BeiGene, Ltd. (NASDAQ:BGNE) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. BeiGene, Ltd. (NASDAQ:BGNE) was in 15 hedge fund portfolios at the end of the first quarter of 2022, compared to 19 funds in the previous quarter. BeiGene, Ltd. (NASDAQ:BGNE) delivered a -4.01% return in the past 3 months.

In May 2022, we published an article that includes BeiGene, Ltd. (NASDAQ:BGNE) in These 5 Stocks Are Getting Crushed Today. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q1 page.

Disclosure: None. This article is originally published at Insider Monkey.